熱門資訊> 正文

标普全球2026年第二季度盈利预览

2026-07-28 00:44

Krystal Biotech(KRYS) 0

S&P Global (SPGI) is scheduled to announce Q2 earnings results on Tuesday, July 28th, before market open.
The consensus EPS Estimate is $5.02 (+13.3% Y/Y) and the consensus Revenue Estimate is $4.12B (+9.6% Y/Y).
Over the last 2 years, SPGI has beaten EPS estimates 88% of the time and has beaten revenue estimates 100% of the time.
Over the last 3 months, EPS estimates have seen 9 upward revisions and 2 downward. Revenue estimates have seen 7 upward revisions and 3 downward.

More on S&P Global

S&P Global: Strong Q2 Expected From The Crown Jewel Segments
S&P Global Inc. (SPGI) Presents at GenAI Fundraising: From Private Rounds to Public Markets Transcript
S&P Global: AI Is A Weak Bear Argument
Krystal Biotech joins the S&P MidCap 400 as TMHC and AVNS exit indexes
Allison Transmission to join S&P MidCap 400; shares up

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。